logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Juliette K Busse

This inventor holds 11 USPTO granted patents. Top assignees: Agouron Pharmaceuticals, Inc., Abbott Laboratories Corporation, Japan Tobacco Inc.. Active years: 1996-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juliette K Busse. Retrieved from https://idiyas.com/inventor/juliette-k-busse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 72.7

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Winthrop Harbor, IL (US) (1996)
  • Solana Beach, CA (US) (1998 - 2002)
  • San Diego, CA (US) (1999 - 2002)

Company Filing History:

goldMedal7 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
silverMedal2 out of 4,189 
 
Abbott Laboratories Corporation
 patents
bronzeMedal2 out of 1,068 
 
Japan Tobacco Inc.
 patents
4. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2002

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6472534 - Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors (2002-10-29),
2. 6465661 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-10-15),
3. 6403799 - Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors (2002-06-11),
4. 6392067 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-05-21),
5. 6316625 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2001-11-13),
6. 6117999 - Methods of making HIV-protease inhibitors and intermediates for making (2000-09-12),
7. 6084107 - Intermediates for making HIV-protease inhibitors (2000-07-04),
8. 5925759 - Methods of making HIV-protease inhibitors and intermediates for making (1999-07-20),
9. 5922849 - Process for preparation of N-demethyl-4'-deoxy-erthromycins A and B (1999-07-13),
10. 5705647 - Intermediates for making HIV-protease inhibitors (1998-01-06),
11. 5580989 - Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]- (1996-12-03),

Title: Juliette K Busse: Innovator in HIV-Protease Inhibitors

Introduction

Juliette K Busse is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of HIV-protease inhibitors. With a total of 11 patents to her name, her work has had a substantial impact on the treatment of HIV.

Latest Patents

Her latest patents include innovative methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors. One notable patent describes methods for converting tetrahydran derivatives into oxazolines, which serve as key reaction intermediates for the preparation of nelfinavir. Additionally, she has developed methods for creating chiral amino alcohols from epoxy-tetrahydrofuran. These advancements are crucial for the synthesis of compounds that inhibit the biological activity of the HIV protease enzyme, effectively halting the replication of the HIV virus.

Career Highlights

Throughout her career, Juliette has worked with notable companies such as Agouron Pharmaceuticals, Inc. and Japan Tobacco Inc. Her expertise in medicinal chemistry has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Juliette has collaborated with esteemed colleagues, including Bennett C Borer and Srinivasan Babu. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Juliette K Busse's contributions to the development of HIV-protease inhibitors exemplify her dedication to advancing medical science. Her innovative methods and collaborative efforts continue to influence the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…